swine
influenza
viru
siv
strong
tropism
pig
respiratori
mucosa
consist
mucu
layer
epithelium
basement
membran
lamina
propria
sialic
acid
present
epitheli
surfac
long
consid
determin
influenza
viru
tropism
howev
mucu
also
rich
sialic
acid
may
serv
first
barrier
select
investig
influenza
viru
interact
mucu
infect
epitheli
cell
two
techniqu
appli
track
siv
porcin
mucu
microscop
diffus
siv
particl
mucu
analyz
singl
particl
track
spt
macroscop
penetr
siv
mucu
studi
viru
incapsulemucu
penetr
system
follow
visual
transloc
virion
time
immunofluoresc
stain
furthermor
effect
neuraminidas
siv
get
bind
mucu
studi
use
zanamivir
neuraminidas
inhibitor
nai
arthrobact
ureafacien
neuraminidas
distribut
diffus
coeffici
show
siv
particl
entrap
rest
diffus
freeli
mucu
addit
siv
penetr
porcin
mucu
time
reach
depth
mm
min
post
viru
addit
fold
min
microscop
diffus
macroscop
penetr
larg
diminish
nai
clearli
increas
effect
exogen
neuraminidas
moreov
exogen
neuraminidas
suffici
prevent
bind
siv
mucu
revers
enhanc
effect
nai
find
clearli
show
neuraminidas
help
siv
move
mucu
import
viru
reach
infect
epitheli
cell
eventu
becom
shed
lumen
respiratori
tract
pig
natur
suscept
three
subtyp
influenza
virus
strong
tropism
pig
respiratori
tract
mucosa
swine
influenza
viru
particl
transmit
direct
contact
air
larg
droplet
aerosol
transmiss
pig
pig
viru
first
encount
mucu
first
barrier
respiratori
tract
overcom
barrier
viru
reach
target
cell
mucos
epithelium
influenza
viru
infect
host
cell
bind
cellular
receptor
via
one
major
viral
glycoprotein
hemagglutinin
ha
ha
bind
sialic
acid
sa
cell
surfac
mediat
subsequ
membran
fusion
lead
viru
entri
neuraminidas
na
catalyz
remov
termin
sialic
acid
cellular
surfac
releas
progeni
viru
well
document
na
function
releas
stage
viru
replic
littl
known
na
play
role
viru
entri
host
cell
even
less
help
viru
overcom
mucu
layer
mucu
complex
mixtur
mucou
glycoprotein
mucin
protein
proteas
proteas
inhibitor
lipid
water
mucin
major
compon
mucu
highli
oglycosyl
glycan
coval
link
via
nacetylgalactosamin
ganac
hydroxyl
group
serin
threonin
residu
mucin
backbon
sugar
chain
mucin
monom
termin
sialic
acid
also
known
cellular
receptor
influenza
virus
hypothes
influenza
virus
bind
extracellular
receptor
get
entrap
mucu
remov
ciliari
clearanc
sever
studi
shown
interact
influenza
viru
mucu
result
competit
inhibit
viru
robert
et
al
show
preincub
human
viru
strain
ferret
nasal
wash
contain
mucu
clearli
reduc
viru
infect
inhibit
correl
competit
bind
viru
alpha
link
sialic
acid
present
mucu
secret
protect
effect
mucu
barrier
confirm
recent
studi
use
transgen
mous
model
overexpress
sa
gal
rich
transgen
mice
challeng
preferenti
bind
show
signific
less
infect
normal
mice
studi
suggest
mucu
mucin
block
influenza
viru
infect
competit
inhibit
hamedi
cell
adsorpt
despit
inhibitori
function
mucu
viru
ultim
abl
reach
suscept
epitheli
cell
long
assum
na
promot
viru
access
target
cell
airway
mucu
degrad
howev
concept
scarc
support
experiment
data
cohen
et
al
incub
viru
human
salivari
mucin
previous
coat
magnet
bead
extens
wash
detect
remain
mucin
show
human
influenza
virus
cleav
away
content
mucin
viral
neuraminidas
effect
cleavag
may
allow
effici
releas
viru
mucu
contrast
find
ehr
et
al
demonstr
strong
protect
upregul
mice
viru
infect
henc
purifi
human
salivari
mucin
may
fulli
reflect
natur
mucu
mucin
highli
modifi
attach
magnet
bead
unravel
mechan
behind
penetr
virus
across
mucos
barrier
potenti
signific
implic
develop
novel
antivir
strategi
therefor
vitro
model
resembl
vivo
situat
need
interact
influenza
viru
natur
mucu
studi
depth
present
studi
aim
address
follow
question
viru
entrap
abl
penetr
nativ
respiratori
mucu
viral
neuraminidas
use
mucin
sialic
acid
substrat
catalyz
cleavag
away
cleavag
suffici
liber
virion
allow
penetr
mucu
layer
purpos
appli
swine
influenza
viru
model
previous
set
use
porcin
respiratori
mucu
pseudorabi
viru
prv
singl
particl
track
spt
addit
penetr
siv
studi
use
mucu
layer
appropri
amount
viru
particl
ad
microscop
diffus
macroscop
transloc
evalu
next
effect
neuraminidas
viru
mobil
mucu
examin
trachea
collect
pig
neg
swine
influenza
virus
shown
hemagglutin
inhibit
hi
test
use
trachea
euthan
anim
approv
ethic
anim
welfar
committe
faculti
veterinari
medicin
ghent
univers
two
day
euthan
pig
treat
intramuscularli
ceftiofur
naxcel
kg
bodi
weight
clear
respiratori
tract
possibl
bacteri
infect
trachea
dissect
mucu
gentli
scrape
spoon
collect
syring
mucu
sampl
store
separ
use
sampl
neg
neuraminidas
determin
na
assay
use
fluoresc
na
substrat
acid
munana
fluoresc
lectin
stain
mucu
freshli
collect
mucu
fill
gelatin
capsul
cm
cm
snap
frozen
methocel
fluka
cryosect
mm
made
trim
interv
mm
section
mucu
section
block
wv
bovin
serum
albumin
h
follow
incub
biotin
conjug
sambucu
nigra
lectin
snai
ey
laboratori
ca
usa
h
room
temperatur
wash
phosphat
buffer
salin
pb
section
incub
streptavidintexa
red
invitrogen
fitc
label
maackia
amurensi
lectin
maa
ey
laboratori
ca
usa
h
room
temperatur
afterward
section
wash
mount
glycerin
contain
octan
dabco
imag
fluoresc
stain
acquir
use
confoc
microscop
leica
tc
laser
scan
spectral
confoc
system
leica
microsystem
gmbh
fluoresc
signal
analyz
imagej
coverag
either
sa
calcul
ratio
fluoresc
signal
region
interest
roi
madin
darbi
canin
kidney
mdck
cell
maintain
minimum
essenti
medium
mem
gibco
supplement
fetal
calf
serum
gibco
mgml
streptomycin
unitsml
penicillin
invitrogen
avianlik
swine
influenza
viru
use
third
passag
mdck
cell
viru
propag
mdck
cell
mem
supplement
mgml
trypsin
gibco
mgml
streptomycin
unitsml
penicillin
gibco
confluent
mdck
cell
inocul
siv
multipl
infect
moi
mem
twenti
hour
post
inocul
supernat
harvest
cellular
debri
remov
ultracentrifug
min
type
rotor
beckman
fullerton
ca
usa
suspens
clarifi
filtrat
mm
filter
millipor
afterward
viru
pellet
h
type
rotor
follow
resuspens
pb
origin
volum
viru
suspens
brought
discontinu
optiprep
sigma
gradient
contain
w
v
iodixanol
centrifug
h
rotor
beckman
fullerton
ca
usa
visibl
opalesc
viru
band
interfac
harvest
separ
buffer
exchang
hne
mm
hepe
mm
nacl
mm
edta
ph
buffer
use
kda
filter
devic
millipor
verifi
puriti
viru
band
doubl
stain
perform
use
perchlor
dio
hyperimmun
swine
serum
direct
influenza
viru
follow
texa
redconjug
goat
antiswin
igg
antibodi
hyperimmun
swine
serum
dilut
mix
viru
suspens
vv
h
incub
ice
texa
redconjug
goat
antiswin
igg
secondari
antibodi
invitrogen
ad
incub
ice
h
afterward
result
mixtur
contain
viru
hyperimmun
serum
secondari
antibodi
equilibr
room
temperatur
dio
solut
mm
dmso
mix
viru
suspens
vv
fierc
vortex
follow
incub
room
temperatur
min
result
suspens
ultracentrifug
h
type
rotor
remov
free
antibodi
dye
resuspens
pb
virion
clarifi
ultracentrifug
h
stain
analyz
confoc
microscop
randomli
select
region
ratio
viral
antigen
posit
particl
virion
versu
dio
posit
particl
calcul
refer
degre
viral
puriti
band
contain
purifi
viru
obtain
buffer
exchang
hne
buffer
incub
dio
solut
previous
describ
viru
suspens
filter
use
sephadex
column
ge
healthcar
belgium
remov
unbound
dye
unlabel
viru
elut
sephadex
column
use
neg
control
dio
lipophil
dye
integr
lipid
compon
viral
envelop
determin
integr
dio
dye
viral
envelop
chang
biophys
properti
viru
size
surfac
charg
zeta
potenti
label
unlabel
virion
measur
dynam
light
scatter
laser
doppler
anemometri
previous
describ
infect
hemagglutin
activ
diolabel
viral
particl
test
viru
titrat
ha
assay
previous
describ
na
enzymat
activ
determin
accord
protocol
adapt
adamo
et
al
briefli
ml
fluoresc
na
substrat
trajectori
fluoresc
viral
particl
porcin
tracheal
respiratori
mucu
record
fast
sensit
electronmultipli
chargecoupl
devic
emccd
camera
cascad
ii
roper
scientif
tucson
az
usa
mount
invert
epifluoresc
microscop
nikon
nikon
belux
brussel
belgium
equip
oilimmers
object
plan
apochromat
nikon
track
experi
perform
presstos
silicon
isol
mm
diamet
mm
deep
invitrogen
merelbek
belgium
previou
studi
show
prv
highli
immobil
nm
pgeylat
bead
diffus
porcin
respiratori
mucu
henc
gfpprv
use
neg
control
latter
use
posit
control
gfpprv
semipurifi
accord
previou
protocol
three
microlit
siv
tcid
ml
prv
tcid
ml
suspens
nm
pegyl
bead
wv
mix
ml
porcin
tracheal
respiratori
mucu
gentl
stir
determin
na
would
affect
siv
diffus
viru
ad
mucu
without
presenc
mm
zanamivir
sigma
muml
arthrobact
ureafacien
neuraminidas
roch
appli
scienc
mixtur
place
custom
made
glass
chamber
sampl
incub
min
microscop
use
stagetop
incub
tokai
hit
fujinomiya
japan
spt
measur
movi
captur
ni
element
ar
softwar
nikon
tempor
resolut
ms
illumin
time
ms
per
frame
trajectori
n
particl
analyz
experi
three
independ
experi
perform
condit
movi
analyz
imag
process
softwar
ip
inhous
develop
softwar
extract
x
posit
data
time
appar
diffus
coeffici
da
calcul
function
time
scale
particl
analysi
movi
perform
ip
centroid
individu
particl
identifi
frame
movi
base
posit
centroid
trajectori
particl
determin
nearest
neighbor
algorithm
appar
diffus
coeffici
da
correspond
first
time
lag
dt
calcul
accord
classic
formula
da
afterward
distribut
diffus
coeffici
particl
obtain
maximum
entropi
method
mem
analysi
freshli
collect
mucu
sampl
ml
ad
gelatin
capsul
cm
cm
creat
mucu
layer
bottom
refer
viru
incapsulemucu
penetr
system
fig
afterward
eight
microlit
viru
suspens
contain
approxim
tcid
purifi
siv
brought
form
droplet
onto
surfac
mucu
immedi
min
min
viru
addit
capsul
snap
frozen
methocel
due
delay
freez
process
time
point
immedi
addit
design
min
determin
na
would
influenc
siv
penetr
viru
ad
without
presenc
mm
zanamivir
sigma
muml
arthrobact
ureafacien
neuraminidas
onto
mucu
follow
snapfreez
min
post
viru
addit
cryosect
mm
made
trim
interv
mm
section
doubl
immunofluoresc
stain
perform
use
mous
lifespan
bioscienc
mous
antinp
atcc
monoclon
antibodi
follow
texa
red
conjug
goat
antimous
alexa
fluor
conjug
goat
antimous
secondari
antibodi
invitrogen
respect
ten
section
made
condit
imag
taken
final
transloc
virion
measur
shown
fig
top
mucu
layer
deepest
point
viral
signal
mucu
section
mm
made
incub
ml
suspens
contain
tcid
siv
presenc
absenc
mm
zanamivir
muml
arthrobact
ureafacien
neuraminidas
h
section
fix
paraformaldehyd
min
follow
permeabil
vv
triton
min
immunofluoresc
stain
perform
use
mous
igg
antibodi
siv
np
follow
goat
antimous
igg
antibodi
conjug
fitc
visual
virion
fluoresc
imag
acquir
randomli
select
region
confoc
microscop
bound
virion
mucu
calcul
imagej
five
section
examin
mucu
sampl
semiquantif
coverag
mucu
section
imag
taken
thu
imag
obtain
sampl
shown
fig
mucu
consist
mix
heterogen
sa
coverag
calcul
ratio
pixel
posit
signal
total
pixel
measur
cover
region
interest
roi
mere
region
constitut
ultracentrifug
discontinu
optiprep
gradient
contain
iodixanol
three
visibl
opalesc
band
collect
name
band
band
band
respect
top
bottom
fig
puriti
viru
band
assess
confoc
microscopi
follow
dio
lipophil
dye
label
siv
immunofluoresc
stain
dio
integr
lipophil
compon
viru
cellular
debri
dio
stain
use
totalparticl
assess
red
color
visual
viral
particl
green
color
repres
diolabel
particl
fig
percentag
doubl
posit
particl
versu
dio
posit
particl
repres
viru
puriti
ratio
extent
consequ
highest
viral
puriti
ratio
doubl
posit
particlesdio
posit
particl
found
band
fig
therefor
viru
prepar
band
use
analysi
incub
mm
dio
dye
room
temperatur
follow
elut
sepharos
column
label
unlabel
siv
analyz
differ
characterist
result
show
hemagglutin
activ
infect
alter
label
neuraminidas
activ
diolabel
siv
unlabel
siv
measur
dynam
light
scatter
laser
doppler
anemometri
size
surfac
charg
label
virion
significantli
alter
tabl
motion
siv
porcin
respiratori
mucu
investig
compar
diffus
prv
nm
pegyl
bead
trajectori
step
analyz
distribut
appar
diffus
coeffici
obtain
similar
previou
data
prv
highli
hinder
porcin
respiratori
mucu
nm
pegyl
bead
diffus
freeli
distribut
diffus
coeffici
clearli
demonstr
compar
one
immobil
fraction
prv
mobil
fraction
nm
bead
siv
experienc
two
diffus
pattern
porcin
respiratori
mucu
viral
particl
trap
rest
particl
move
rapidli
fig
averag
diffus
coeffici
siv
mucu
higher
prv
fig
similar
size
nm
pegyl
bead
mucoinnert
indic
particl
interact
type
mucu
moieti
thu
opposit
viral
particl
immobil
probabl
due
bind
interact
mucu
data
suggest
bind
releas
effect
present
interact
siv
porcin
respiratori
mucu
depth
siv
penetr
could
visual
doubl
immunofluoresc
stain
siv
nucleoprotein
np
distanc
surfac
deepest
point
viru
transloc
measur
design
depth
viru
penetr
fig
three
independ
experi
perform
total
measur
conduct
distribut
penetr
depth
condit
eventu
obtain
immedi
viru
addit
virion
rapidli
enter
mucu
layer
reach
depth
mm
within
min
due
passiv
diffus
effect
fig
incub
virion
spread
mucu
time
distribut
penetr
depth
show
major
siv
particl
travel
mm
mucu
min
viru
addit
reach
depth
mm
min
addit
fig
similarli
microscop
diffus
distribut
siv
penetr
clearli
show
two
fraction
min
viru
addit
fig
viral
particl
penetr
min
min
post
viru
addit
fig
averag
depth
viru
penetr
min
significantli
higher
earlier
time
point
fig
suggest
siv
virion
abl
activ
penetr
mucu
layer
movi
captur
spt
softwar
siv
microscop
diffus
mucu
presenc
absenc
zanamivir
exogen
neuraminidas
analyz
ip
shown
fig
mobil
fraction
siv
diffus
sever
diminish
nai
treatment
elev
addit
arthrobact
ureafacien
neuraminidas
approxim
mobil
viral
particl
da
larger
mm
becam
stuck
effect
zanamivir
wherea
exogen
neuraminidas
increas
mobil
particl
approxim
fig
consist
presenc
zanamivir
viru
suspens
almost
complet
inhibit
siv
macroscop
penetr
contrast
penetr
effect
exogen
neuraminidas
fig
averag
penetr
mock
treat
siv
significantli
higher
nai
treat
viru
rise
averag
penetr
mock
neuraminidas
treat
viru
also
signific
fig
data
impli
neuraminidas
help
siv
penetr
porcin
respiratori
mucu
viru
attach
mucu
section
visual
immunofluoresc
stain
siv
np
viru
bind
mucu
section
analyz
imag
taken
section
total
imag
obtain
virion
quantif
virion
attach
mucu
region
mm
calcul
three
independ
experi
perform
repres
confoc
photomicrograph
show
zanamivir
clearli
enhanc
attach
siv
mucu
contrast
exogen
neuraminidas
deplet
viru
bind
mucu
fig
data
clearli
demonstr
na
abl
releas
siv
particl
may
bound
interact
ha
mucin
move
virion
mucu
influenza
virus
highli
contagi
readili
spread
aerosol
transmiss
mucu
first
barrier
small
aerosol
droplet
settl
overcom
present
studi
appli
spt
techniqu
custom
made
viru
incapsulemucu
penetr
system
visual
microscop
diffus
macroscop
penetr
siv
porcin
respiratori
mucu
spt
uniqu
model
rigor
analysi
virusmucu
interact
mobil
point
view
viru
incapsulemucu
penetr
system
allow
visual
viru
penetr
mucu
layer
therebi
mimick
natur
condit
use
model
abl
track
diffus
siv
natur
respiratori
mucu
spt
assay
two
fraction
base
viru
diffus
coeffici
mobil
immobil
fraction
abil
siv
detach
mucu
attribut
na
activ
inhibit
na
use
zanamivir
significantli
suppress
liber
viru
mucu
network
fig
also
line
previou
report
matrosovich
et
al
describ
block
na
activ
oseltamivir
effici
inhibit
influenza
virus
infect
differenti
human
airway
epithelium
cultur
probabl
cover
mucin
secret
furthermor
exogen
neuraminidas
shown
promot
microscop
diffus
macroscop
penetr
detect
spt
viru
incapsulemucu
penetr
system
fig
confirm
benefici
effect
neuraminidas
releas
siv
respiratori
mucu
also
highlight
bidirect
synergist
interact
influenza
viru
bacteri
infect
influenza
viru
predisposit
secondari
bacteri
infect
thoroughli
studi
howev
littl
inform
exist
regard
impact
bacteri
neuraminidas
influenza
viru
entri
transmiss
research
need
neuraminidas
indic
play
role
siv
releas
mucu
howev
two
fraction
viral
motion
mucu
lead
discuss
way
viru
bind
mucu
mucin
major
constitut
mucu
highli
decor
glycan
termin
sialic
acid
thu
like
attribut
immobil
siv
porcin
respiratori
mucu
mucin
may
play
direct
indirect
role
host
defens
distinct
abil
form
adhes
decoy
addit
mucin
aqueou
mucu
layer
consist
great
number
host
defens
agent
includ
lysozym
lactoferrin
secretori
iga
siga
collectin
defensin
cathelicidin
histatin
surfact
protein
molecul
may
function
bind
virion
receptorindepend
pattern
shown
surfact
protein
spd
bind
via
carbohydr
recognit
domain
ca
depend
manner
nlink
highmannos
carbohydr
present
ha
na
influenza
virus
addit
siga
retain
high
concentr
mucu
effici
trap
pathogen
last
least
defensin
great
interest
respect
respiratori
viral
infect
human
defensin
shown
bind
sever
type
virus
inhibit
entri
virus
target
cell
compon
may
retain
mucu
direct
bind
mucin
biophys
properti
mucu
thu
becom
part
gel
network
provid
immobil
reservoir
protect
effector
altern
possibl
viral
particl
immobil
mucu
actual
incomplet
defect
virion
becam
inact
prepar
product
defect
particl
report
influenza
virus
howev
approach
distinguish
activ
inact
virion
entiti
readili
achiev
examin
vaccin
remain
primari
option
prevent
control
influenza
antiinfluenza
viru
drug
consid
complementari
approach
vaccin
product
may
rapidli
achiev
find
provid
experiment
evid
essenti
role
na
influenza
viru
penetr
respiratori
mucu
block
na
activ
clearli
suppress
movement
viru
mucu
fig
illustr
na
play
role
remov
sialic
acid
mucin
may
enabl
viru
gain
access
cellular
receptor
suggest
use
neuraminidas
inhibitor
prophylact
treatment
influenza
hand
prevent
treatment
oseltamivir
tamiflu
fail
protect
lung
viru
replic
inflamm
vivo
influenza
infect
studi
pig
despit
reduc
clinic
symptom
viru
shed
highlight
complex
vivo
situat
minim
benefit
neuraminidas
inhibitor
may
abil
influenza
viru
pass
mucu
may
serv
determin
influenza
viru
transmiss
addit
effici
viru
attach
high
potenti
replic
low
infecti
dose
requir
combin
studi
cohen
et
al
notic
human
influenza
virus
could
bind
releas
human
salivari
mucin
porcin
submaxillari
mucin
wherea
swine
influenza
viru
abl
escap
porcin
airway
mucu
suggest
may
differ
interact
differ
influenza
virus
mucu
differ
speci
balanc
bind
releas
mucin
sialic
acid
determin
function
balanc
ha
na
may
influenc
effici
viru
avoid
stick
mucu
fluoresc
lectin
stain
mucu
cryosect
show
present
porcin
respiratori
mucu
distinct
predomin
latter
fig
bind
profil
siv
strain
investig
studi
howev
well
document
swine
influenza
viru
isol
especi
avianlik
hemagglutinin
show
receptor
specif
glycan
probabl
mucu
provid
suffici
amount
receptor
siv
bind
bind
siv
via
ha
porcin
respiratori
mucu
prove
present
studi
amount
viral
exogen
na
inde
modul
extent
viral
bind
releas
porcin
mucu
fig
concern
releas
effect
na
mediat
process
also
substrat
prefer
demonstr
na
human
swine
influenza
virus
preferenti
specif
although
cleav
link
sialyl
glycan
therefor
assum
sialic
acid
respiratori
mucu
secret
may
exert
effect
influenza
viru
transmiss
sinc
major
viral
particl
incap
penetr
mucu
layer
influenza
virus
invad
respiratori
tract
anim
base
experiment
find
present
literatur
propos
sever
strategi
influenza
virus
may
use
overcom
mucu
barrier
find
way
establish
infect
product
enzym
aid
viru
movement
mucu
influenza
viru
bind
use
sialic
acidcontain
molecul
receptor
capabl
influenza
viru
evolv
second
viral
surfac
protein
neuraminidas
receptordestroy
enzym
cleav
sialic
acid
allow
viru
releas
bind
sialic
acidcontain
molecul
lead
viral
infect
strategi
util
well
mani
microb
e
histolytica
vibrio
cholera
helicobact
pylori
reoviru
coronaviru
subvert
avoid
mucu
barrier
product
enzym
includ
mucinas
sialidas
glycosidas
elastas
hydrolas
capabl
degrad
mucin
core
protein
mucin
carbohydr
facilit
microb
swim
mucu
layer
furthermor
enzym
microb
produc
may
also
facilit
invas
pathogen
women
bacteri
vaginosi
overgrowth
anaerob
gramneg
bacteria
produc
sialidas
glycosidas
mucindegrad
enzym
caus
breakdown
barrier
properti
cervicovagin
mucu
therebi
destroy
mucu
gel
help
sexual
transmit
pathogen
human
immunodefici
viru
hiv
invad
use
abund
ubiquit
molecul
receptor
although
may
risk
bind
decoy
receptor
use
abund
ubiquit
molecul
receptor
provid
appar
advantag
viru
allow
infect
multipl
cell
type
speci
result
low
minim
infecti
dose
initi
infect
base
data
diffus
penetr
effect
mucu
network
virion
encount
extrem
part
particl
escap
reach
suscept
target
cell
ultim
thu
virus
requir
lower
minim
infecti
dose
tissu
may
gain
higher
chanc
establish
infect
spread
via
aerosol
slow
settl
aerosol
air
caus
prolong
contact
viru
respiratori
tract
benefit
viru
penetr
mucu
layer
furthermor
aerosol
droplet
travel
much
effici
lower
respiratori
tract
mucociliari
apparatu
may
need
longer
time
transport
exclud
virion
respiratori
tract
increas
chanc
virus
penetr
mucu
layer
reach
target
cell
eventu
issu
siv
would
abl
penetr
porcin
respiratori
mucu
neuraminidas
would
contribut
move
viru
mucu
layer
address
howev
abil
viral
neuraminidas
cleav
sialic
acid
mucu
investig
due
technic
limit
viscou
properti
imped
separ
free
sialic
acid
mucu
even
would
cleav
viral
neuraminidas
investig
role
influenza
viru
neuraminidas
cleavag
sialic
acid
mucu
may
shed
light
unravel
mechan
influenza
pneumonia
henc
effect
influenza
viru
neuraminidas
mucu
need
studi
